New AI tool could spot dangerous liver cancer invasion without a biopsy

NCT ID NCT07170345

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is testing an artificial intelligence system that analyzes CT scans to predict microvascular invasion (MVI) in liver cancer patients. MVI is a key sign of aggressive cancer that currently can only be confirmed after surgery. The AI tool aims to give doctors this information beforehand, helping them plan better surgeries and treatments. The trial will enroll 400 adults with liver cancer who are scheduled for surgery, comparing the AI's predictions to standard lab results.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Artificial intelligence-based computer-aided diagnosis (CAD) system

What this could lead to

If successful, this could provide doctors with a reliable, non-invasive tool to predict microvascular invasion before surgery, helping tailor treatment and potentially improve survival for liver cancer patients.

What could go wrong

This is an early-stage observational study, and the AI system may not perform accurately across different hospitals or patient groups. It is not yet proven to improve patient outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatocellular carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beijing Tsinghua Changgeng Hospital

    RECRUITING

    Beijing, China

    Contact

  • Beijing YouAn Hospital

    RECRUITING

    Beijing, China

    Contact

  • Dazhou Central Hospital

    RECRUITING

    Dazhou, Sichuan, China

    Contact

  • Eastern Hepatobiliary Surgery Hospital

    RECRUITING

    Shanghai, China

    Contact

  • Fifth Affiliated Hospital, Sun Yat-Sen University

    RECRUITING

    Zhuhai, Guangdong, China

    Contact

  • First Affiliated Hospital of Guangxi Medical University

    RECRUITING

    Nanning, Guangxi, China

    Contact

  • First Affiliated Hospital of Kunming Medical University

    RECRUITING

    Kunming, Yunnan, China

    Contact

  • First Affiliated Hospital of Wenzhou Medical University

    RECRUITING

    Wenzhou, Zhejiang, China

    Contact

  • Guangdong Provincial Hospital of Traditional Chinese Medicine

    RECRUITING

    Guangzhou, Guangdong, China

    Contact

  • Guizhou Provincial People's Hospital

    RECRUITING

    Guiyang, Guizhou, China

    Contact

  • Henan Provincial People's Hospital

    RECRUITING

    Zhengzhou, Henan, China

    Contact

  • Meng Chao Hepatobiliary Hospital of Fujian Medical University

    RECRUITING

    Fuzhou, Fujian, China

    Contact

  • Peking Union Medical College Hospital

    RECRUITING

    Beijing, China

    Contact

  • Shengjing Hospital

    RECRUITING

    Shenyang, Liaoning, China

    Contact

  • The First People's Hospital of Yunnan Province

    RECRUITING

    Kunming, Yunnan, China

    Contact

  • West China Hospital

    RECRUITING

    Chengdu, Sichuan, China

    Contact

  • Yunnan Cancer Hospital

    RECRUITING

    Kunming, Yunnan, China

    Contact

  • Zhuhai People's Hospital

    RECRUITING

    Zhuhai, Guangdong, China

    Contact

  • Zhujiang Hospital

    RECRUITING

    Guangzhou, Guangdong, China

    Contact